COX JOHN (CEO & President) received a stock award from DYNE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2026ACC: 0001193125-26-055075
DirectorOfficer· CEO & President
Since Mar 2026
+465K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
465K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+180K
Price / share
—
Trade value
—
% of position
91.4%
2/12/2026
196.88K→376.88K
Total
Net shares
+180K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +180K | — | — | 91.4% | 196.88K | 376.88K |
| Total | +180K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
285K shares
Shares
+285K
Strike price
16.00
Held after
285K
Exercisable
—
2/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock285K shares | 2/12/2026 | A · Award | +285K | 16.00 | — | 285K |
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Total
72K indirect72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Total | 72K | 72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported